No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹1.77Prev. Close
₹1.77Turnover(Lac.)
₹0.49Day's High
₹1.81Day's Low
₹1.7752 Week's High
₹2.8352 Week's Low
₹1.75Book Value
₹1.1Face Value
₹1Mkt Cap (₹ Cr.)
7.08P/E
19.67EPS
0.09Divi. Yield
04 Sep 2025
12:00 AM
AGM
Announcement Date: 04 Sep, 2025
28 Apr 2026
12:00 AM
Board Meeting
Agenda : Audited Result
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 4 | 4 | 4 | 4 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 0.02 | 0.72 | 0.4 | -0.17 |
Net Worth | 4.02 | 4.72 | 4.4 | 3.83 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 9.14 | 9.22 | 9.42 | 6.44 |
yoy growth (%) | -0.82 | -2.18 | 46.4 | 85.35 |
Raw materials | -8.48 | -8.56 | -9.13 | -5.52 |
As % of sales | 92.71 | 92.83 | 96.88 | 85.85 |
Employee costs | -0.11 | -0.29 | -0.25 | -0.1 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.46 | 0.14 | -0.2 | 0.26 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | 0 | -0.04 | 0 | -0.02 |
Working capital | 4.72 | 0.09 | -1.25 | 0.48 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -0.82 | -2.18 | 46.4 | 85.35 |
Op profit growth | -61.07 | -141.68 | -147.48 | -495.32 |
EBIT growth | 41.27 | 166.09 | -63.7 | -651.11 |
Net profit growth | 364.35 | -149 | -184.9 | -251.1 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 115.91 | 7.42 | 27.84 | 17.81 | 10.4 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 115.91 | 7.42 | 27.84 | 17.81 | 10.4 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.11 | 0.06 | 0.05 | 0.48 | 0.83 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,845.2 | 101.44 | 4,42,725.29 | 608.7 | 0.87 | 4,887.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,885 | 71.05 | 1,82,775.12 | 756 | 0.43 | 2,793 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,484.15 | 67.95 | 1,51,764.01 | 467 | 0.13 | 2,677 | 249.82 |
Cipla Ltd CIPLA | 1,398.95 | 30.54 | 1,13,007.26 | 384.64 | 0.93 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,307.1 | 33.88 | 1,09,098.01 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & MD
Jayendra Mehta
Independent Non Exe. Director
Rina Kumari
Independent Non Exe. Director
Hitesh Pradeep Rijwani
Non-Exec & Non-Independent Dir
SARANG PATHAK
403 Sarthik 2 Opp Rajpath Club,
S G Highway,
Gujarat - 380054
Tel: 91-07405699869
Website: http://www.iveeinjectaa.com
Email: info@iveeinjectaa.com; info@vivanzabiosciences.com
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 022- 23016761 / 2301
Website: www.purvashare.com
Email: support@purvashare.com
Summary
Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Due to re...
Read More
Reports by Vivanza Biosciences Ltd
What is the Vivanza Biosciences Ltd share price today?
What is the Market Cap of Vivanza Biosciences Ltd?
What is the PE and PB ratio of Vivanza Biosciences Ltd?
What is the 52 Week High and Low of Vivanza Biosciences Ltd?
What is the CAGR of Vivanza Biosciences Ltd?
What is the shareholding pattern of Vivanza Biosciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
